GreenLight Biosciences is the subject of a $2,000,000 securities class action settlement stemming from its 2023 merger, in which shareholders received $0.30 per share when the deal closed on July 24, 2023. Record and beneficial holders of GreenLight Biosciences Holdings, PBC common stock who held shares during the tender offer period of June 21 through July 20, 2023 may be eligible for approximately $0.04 per share after deductions, subject to a $10 minimum payment threshold. The verified claim deadline is July 29, 2026 — proof of your shareholding is required.